STUDY ON THE BACTERIOLOGICAL PROFILE OF URINARY TRACT INFECTION AND ANTIBIOTICS SENSITIVITY PATTERN IN A TERTIARY CARE HOSPITAL, JAMNAGAR, GUJARAT

S.C. GAMIT¹*, K.D. MEHTA², S. MULLAN^3
1Department of Microbiology, M.P.Shah Govt. Medical College, Jamnagar, 361008, Saurashtra University, Rajkot, 360 005, Gujarat, India
²Department of Microbiology, M.P.Shah Govt. Medical College, Jamnagar, 361008, Saurashtra University, Rajkot, 360 005, Gujarat, India
³Department of Microbiology, M.P.Shah Govt. Medical College, Jamnagar, 361008, Saurashtra University, Rajkot, 360 005, Gujarat, India
* Corresponding Author : saurabhgamit@gmail.com

Received : 03-05-2019     Accepted : 26-05-2019     Published : 30-05-2019
Volume : 11     Issue : 5       Pages : 1573 - 1575
Int J Microbiol Res 11.5 (2019):1573-1575

Keywords : Female, Urinary tract infection, Antimicrobial susceptibility, E. coli
Conflict of Interest : None declared
Acknowledgements/Funding : Authors are thankful to Department of Microbiology, M.P.Shah Govt. Medical College, Jamnagar, 361008, Saurashtra University, Rajkot, 360 005, Gujarat, India
Author Contribution : All authors equally contributed

Urinary tract infection (UTI) is defined as a disease caused by microbial invasion of the urinary tract that extends from the renal cortex of kidney to the urethral meatus. Urinary tract infections (UTIs) are among most common bacterial infections that need medical care; accounting for second most common infection after respiratory tract infections in community. Whereas in hospitals, they are the most common hospital acquired infections (HAIs) accounting for 35% of total HAIs. Approximately half population of women will have a UTI during their lifetime. Escherichia coli are the most common cause of UTIs. Clean-Catch midstream urine was collected of the patients with history of fever, abdominal pain, dysuria, urgency and frequency. During study 343 urine samples received in microbiology laboratory for culture were processed according to standard protocol. Isolates were identified by conventional phenotypic methods and antibiotic sensitivity determined by standard Kirby Bauer disc diffusion method and follow Clinical and Laboratory Standards Institute (CLSI) guidelines. In this study 86 (25.07%) patients out of 343 were shown to be urine culture positive out of them 54 (62.79%) females and 32 (37.21%) males. The most isolated bacterium was E. coli with frequency rate of 54 (62.79%). The other bacteria were Klebsiella spp. 20(23.26%), Pseudomonas spp. 07 (8.14%), and other gram negative bacteria 05 (5.81%). The study suggests that Gram-negative bacilli were responsible for UTI infections. The most common isolated organism from urinary tract infections were E. coli followed by Klebsiella pneumoniae. The most effective antimicrobial agents were Imipenem and Piperacillin-tazobactam and the least effective one was cephalexin.

1. Demilie T., Beyene G., Melaku S., Tsegaye W. Ethiop. (2012) J. Health Sci., 22(2),121-128.
2. Parveen S.S., Reddy S.V., Rama Rao M.V., Janardhan Rao R. (2011) Ann Biol Res.,2(5),516-521.
3. Ahmed E., Shahid H.M., Ikhlaque S.S., Ejaz M. (2014) J. Rawalpindi Med. Coll., 18(2), 263-266.
4. Omigie O., Okoror L., Umolu P., Ikuuh G. (2009) Int. J. Gen. Med.,2,171-175.
5. Al-Badr A., Al-Shaikh G. Sultan Qaboos (2013) Univ. Med. J., 13(3),359-367.
6. Rowe T.A., Juthani-Mehta M. (2013) Aging Health, 9, 5.
7. Vasudevan R. (2015) EC Microbiol.,1,88-112.
8. Verstraelen H., Verhelst R., Vaneechoutte M., Temmerman M. (2010) BMC Infect. Dis., 10,81.
9. Flores-Mireles A.L., Walker J.N., Caparon M., Hultgren S.J. (2015) Nat. Rev. Microbiol., 13(5),269-284.
10. Lee-Ellen C. Copstead-Kirkhorn, Jacquelyn L. Banasik (2013) Elsevier Health Sciences, 272.
11. Foxman B. (2002) Am J Med., 113 Suppl 1A, 5S-13S.
12. Abubakar E.M. (2009) J. Clin Med Res., 1(1),001-008.
13. Wilson J.M., Fenoff R. (2011) global edge business review Available at: http://royfenoff.com/ Global_Edge_Business_Review_Article.pdf.
14. CLSI. Performance standards for antimicrobial disk tests; Approved Standards. 25th Edition. Clinical and Laboratory Standards Institute (CLSI) Document M2-A9. Wayne. 2016;26(1).
15. Angoti G., Goudarzi H., Hajizadeh M. & Tabatabaii Z. (2016) Novelty in Biomrdicine, 4(1), 1-4.
16. Solanki Manoj, Surani Chandani, Mehta Krunal, Mullan Summaiya. (2018) Saudi Journal of Pathology and Microbiology, 3(12), 488- 49
17. Singh V.P., Mehta A. (2017) Int J Res Med Sci.,5,2126-9.
18. Bency J.A.T., Priyanka R., Jose P. (2017) Int J Res Med Sci.,5,666-9.